|
Volume 8, Review 57 |
August 1998 |
|
V.F. Tapson, F. Paganin |
|
Editorial |
|
D. Lew |
|
A pragmatic approach to community-acquired pneumonia: patients and pathogens |
|
M. Woodhead |
|
Community-acquired pneumonia: focusing on the patient |
|
V.F. Tapson |
|
Risk factors in community-acquired pneumonia: can they be quantified? |
|
M. El-Ebiary |
|
Community-acquired pneumonia: assessment of therapy |
|
H. Lode |
|
The experience from clinical trials with a new quinolone for community-acquired pneumonia |
|
304 |
Discussion |